Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort
Research output: Contribution to journal › Article
Colleges, School and Institutes
- University of Manchester
The metabolic syndrome (MetS) may contribute to the increased cardiovascular risk in systemic lupus erythematosus (SLE). We examined the association between MetS and disease activity, disease phenotype and corticosteroid exposure over time in patients with SLE.
|Journal||Annals of the Rheumatic Diseases|
|Publication status||Published - 1 Apr 2014|